Iskandar, I. Y., Warren, R. B., Lunt, M., Mason, K. J., Evans, I., McElhone, K., . . . Griffiths, C. E. (2018). Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). J Invest Dermatol.
Citação norma ChicagoIskandar, Ireny Y.K., et al. "Differential Drug Survival of Second-Line Biologic Therapies in Patients With Psoriasis: Observational Cohort Study From the British Association of Dermatologists Biologic Interventions Register (BADBIR)." J Invest Dermatol 2018.
MLA citiranjeIskandar, Ireny Y.K., et al. "Differential Drug Survival of Second-Line Biologic Therapies in Patients With Psoriasis: Observational Cohort Study From the British Association of Dermatologists Biologic Interventions Register (BADBIR)." J Invest Dermatol 2018.